Quantcast

Latest SRI Biosciences Stories

2014-09-09 12:29:19

MENLO PARK, Calif., Sept. 9, 2014 /PRNewswire/ -- SRI International, an independent nonprofit research institute, and Nobelpharma, a Japanese pharmaceutical company, have entered into a licensing agreement to test SR16234, an SRI drug candidate that may be effective in treating endometriosis. SR16234 is a member of a class of drugs known as selective estrogen receptor modulators (SERMs) that regulate the effects of the hormone estrogen. "This important collaboration is addressing a...

2014-07-24 12:27:52

MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct preclinical development of potential therapies for HIV infection and AIDS. The contract supports the development of drugs to treat HIV and AIDS and the complications and opportunistic infections associated with the disease, as well as...

2014-05-07 08:31:53

New Model May Also Explain How Narcolepsy Develops in Humans MENLO PARK, Calif., May 7, 2014 /PRNewswire/ -- Neuroscientists at SRI International have found that a form of baclofen, a drug used to treat muscle spasticity, works better at treating narcolepsy than the best drug currently available when tested in mice. http://photos.prnewswire.com/prnvar/20140506/85139 According to the National Institute of Neurological Disorders and Stroke (NINDS), narcolepsy, a chronic...

2014-04-16 12:30:22

Advanced Tumor Modeling for Evaluation of Cancer Therapy Efficacy at the Cellular Level MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- SRI International has announced the availability of its PDCellX(TM) xenograft tumor model services for testing the activity of potential cancer therapeutics. PDCellX models provide clinically relevant information that allows researchers to evaluate the efficacy of cancer drug candidates in new models that go beyond traditional tumor xenograft...

2014-01-06 16:23:01

Researchers will synthesize molecules to support the new field of metabolomics MENLO PARK, Calif., Jan. 6, 2014 /PRNewswire/ -- SRI International has received a $4.5 million contract from the National Heart, Lung and Blood Institute, part of the National Institutes of Health, to establish a Metabolite Standards Synthesis Center to prepare molecules for researchers to use in the emerging field of metabolomics. Like genomics and proteomics, which study the collective characterization...

2010-11-15 12:59:00

MENLO PARK, Calif., Nov. 15, 2010 A presentation on strategic collaboration opportunities with SRI's Biosciences Division. SRI's well-funded researchers operate as a nonprofit pharmaceutical organization and have the resources to provide complete drug discovery and development capabilities - from "Idea to IND"(R). SRI is currently seeking partners at all preclinical phases of basic research, drug WHAT:...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.